Immunosuppressive factor derived from renal cancer cells.

Area of Science:

• Immunology
• Cancer Biology
• Cellular Signaling

Background:

• Renal cancer cell lines can secrete factors influencing immune responses.
• Understanding immunosuppression in cancer is crucial for developing immunotherapies.
• The KU2 human renal cancer cell line's secretome was investigated for immunomodulatory properties.

Purpose of the Study:

• To characterize an immunosuppressive factor produced by the KU2 human renal cancer cell line.
• To determine the mechanism of action of this factor on normal lymphocytes.
• To investigate the requirements for the production of this immunosuppressive factor.

Main Methods:

• Culturing the KU2 human renal cancer cell line and collecting conditioned medium.
• Assessing the effect of conditioned medium on mitogen-activated normal peripheral blood lymphocytes.
• Measuring [3H]-thymidine incorporation into lymphocyte DNA.
• Quantifying Interleukin-2 production by activated lymphocytes.
• Evaluating the factor's stability (heat sensitivity, dialysis).
• Investigating the role of DNA replication in factor production.

Main Results:

• The conditioned medium suppressed lymphocyte proliferation ([3H]-thymidine incorporation) in a dose-dependent manner.
• The observed immunosuppression was cytostatic and reversible.
• The factor inhibited early-stage lymphocyte activation and Interleukin-2 production.
• The factor was non-dialyzable and inactivated by heat treatment at 56°C.
• DNA replication within the KU2 cells was essential for the production of the immunosuppressive factor.

Conclusions:

• A heat-sensitive, non-dialyzable immunosuppressive factor is produced by the KU2 human renal cancer cell line.
• This factor inhibits normal lymphocyte activation and Interleukin-2 production, suggesting a role in tumor-induced immunosuppression.
• The production of this factor is dependent on the replicative state of the cancer cells, offering potential therapeutic targets.